Interactions between Tacrolimus and Metronidazole in a renal transplant patient

Interactions between Tacrolimus and Metronidazole in a renal transplant patient

Bibliographic Details
Main Authors:	Catic-Djordjevic Aleksandra, Velickovic-Radovanovic Radmila, Stefanovic Nikola, Cvetkovic Tatjana
Format:	Article
Language:	English
Published:	De Gruyter 2012-10-01
Series:	Open Medicine
Subjects:	interactions metronidazole tacrolimus renal transplantation
Online Access:	https://doi.org/10.2478/s11536-012-0035-7

Similar Items

Pharmacogenetics may influence tacrolimus daily dose, but not urinary tubular damage markers in the long-term period after renal transplantation
by: Stefanović Nikola Z., et al.
Published: (2015-01-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Tacrolimus as a rare cause of pericardial effusion in a renal transplant recipient
by: Rohini Prashar, et al.
Published: (2017-01-01)

A prospective study of correlation of blood levels of tacrolimus to graft function and adverse effect of tacrolimus in postrenal transplant patients
by: Krishna Asuri, et al.
Published: (2020-01-01)

Comparison of patient and graft survival in tacrolimus versus cyclosporine-based immunosuppressive regimes in renal transplant recipients – Single-center experience from South India
by: Kiran Chandra Patro, et al.
Published: (2018-01-01)

Influence of CYP3A5 and ABCB1 polymorphism on tacrolimus drug dosing in South Indian renal allograft recipients
by: M Edwin Fernando, et al.
Published: (2019-01-01)

Déterminants moléculaires de la néphrotoxicité induite par le tacrolimus après transplantation rénale
by: Van Der Hauwaert, Cynthia
Published: (2014)

SIGNIFICANCE OF THERAPY MONITORING OF IMMUNOSUPPRESSIVE MEDICINES IN RENAL TRANSPLANTATION PATIENTS
by: Vidojko Đorđević, et al.
Published: (2009-04-01)

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients
by: Yilei Yang, et al.
Published: (2021-07-01)

Influence of different formulations of tacrolimus on dosage regimen and drug exposure within the first year after kidney transplantation
by: Stefanović Nikola Z., et al.
Published: (2019-01-01)

Tacrolimus-induced pure red cell aplasia in a postrenal transplant patient
by: Prakash Khetan, et al.
Published: (2019-01-01)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

Unilateral common peroneal nerve palsy following renal transplantation: A case report of tacrolimus neurotoxicity
by: A Jain, et al.
Published: (2011-01-01)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
by: Hideaki Kagaya, et al.
Published: (2018-03-01)

Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients
by: Daniel A. Brazeau, et al.
Published: (2020-08-01)

HEMOFILTRATION AND COUPLED PLASMA FILTRATION ADSORPTION IMPACT ON TACROLIMUS BLOOD CONCENTRATION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01)

HSD11B1 rs846908 polymorphisms and tacrolimus concentrations: quantum chemical analysis and implication in patients with renal transplantation
by: Beuy Joob, et al.
Published: (2017-01-01)

Current biochemical monitoring and risk management of immunosuppressive therapy after transplantation
by: Catić-Đorđević Aleksandra, et al.
Published: (2017-01-01)

Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)

Renal Allograft Dysfunction Possibly Caused by Amiodarone Nephrotoxicity: a Case-Report
by: Basic-Jukic Nikolina, et al.
Published: (2017-06-01)

Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
by: Johannes von Einsiedel, et al.
Published: (2020-06-01)

Early tacrolimus administration induced encephalopathy in a renal transplanted patient; a case report
by: Fatemeh Yaghoubi, et al.
Published: (2017-04-01)

Tacrolimus-induced Ascites after Liver Transplant
by: M Hosseini, et al.
Published: (2018-04-01)

Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01)

Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol: Differences or similarities?
by: Cvetković Tatjana, et al.
Published: (2015-01-01)

An analysis of tacrolimus-related complications in the first 30 days after liver transplantation
by: Lucas Souto Nacif, et al.
Published: (2014-11-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

Therapeutic drug monitoring of tacrolimus in pancreas transplantation at São Lucas Hospital Monitoramento terapêutico de tacrolimus em transplante de pâncreas no Hospital São Lucas
by: Luciana Mello de Oliveira, et al.
Published: (2007-10-01)

Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage Post-Renal Transplantation
by: Takenori Niioka, et al.
Published: (2015-01-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Effects of Corticosteroid Treatment on Mycophenolic Acid Exposure in Renal Transplant Patients—Results From the SAILOR Study
by: Nima Nourbakhsh, et al.
Published: (2021-09-01)

Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Gerold Thölking, et al.
Published: (2021-02-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

Anemia hemolítica microangiopática induzida por tacrolimus e ciclosporina A Microangiopathic hemolytic anemia induced by tacrolimus and ciclosporine A
by: Rafael S. Vasconcelos, et al.
Published: (2008-12-01)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017-01-01)

Effect of tacrolimus on the results of living related kidney donor transplantation
by: V A Goriaĭnov, et al.
Published: (2014-06-01)

A case of tacrolimus-induced encephalopathy after kidney transplantation
by: Myoung Uk Kim, et al.
Published: (2011-01-01)